Harshal Shah, Cambridge Consultants - Qepler Summits And Conferences

Harshal Shah

Vice President, Global Medical Technology Division
Cambridge Consultants
Boston, USA
Cambridge Consultants

Harshal Shah is part of Cambridge Consultant’s Global Medical Technology Division. He primarily focuses on novel drug delivery systems and innovations in the field of Oncology.

Harshal has deep commercial understanding of the scientific and engineering innovations in the field of administration of biologics through advance delivery devices and systemic delivery of biologics, proteins and peptides through inhalation route. He has significant domain expertise in oncology patient journey, economics of cancer care, latest industry trends in R&D, and commercialization strategy. His current and past projects include end-to-end drug-device combination product development, manufacturing tec-transfer, life cycle management, commercial launch, technology innovation and device focused regulatory strategy.

He has 12+ years of progressive strategy and management consulting experience in pharmaceutical, biotech and medical device industry. Past experiences include working with Bristol-Myers Squibb, Johnson & Johnson, Merck and over 15 other major companies in consulting role while working with PRTM Management Consultants and as principal of Labyrintheus Consulting.

He has Bachelor of Mechanical Engineering from Nirma Institute of Technology, India and MBA in Supply Chain and Finance from Syracuse University, New York.

He is avid traveler and has been to 50+ countries on adventure, photography and cultural expeditions. He lives in Boston. He can be reached at +1.609.529.2891 / Harshal.Shah[at]CambridgeConsultants.com.

Related Sessions:

Pre-Filled Syringes
Summit 2018

Enhance a fully integrated system approach for developing pre-filled syringes to maintain patient centricity.
  • 31 May 2018
  • Berlin, DE
  • Pharma
Day 1: Thursday, 31 May 2018
BLOCK: TRENDS IN SELF INJECTION DRUG DELIVERY.
CASE STUDY: Pre-loaded / Pre-filled large volume injectors.
  • Brief overview of LVI platform landscape.
  • Unmet needs and future direction of care delivery models.
  • Challenges in design and development of pre-filled and pre-loaded wearable devices.
  • Path forward.
View Details